Trigger finger is a common cause of pain and disability in the hand. It is also the fourth most common reason for referral to the hand outpatient clinic and accounts for 1 in 18 of all referrals to our unit. The condition is, however, not solely managed by hand surgeons as it is often treated in the community and by specialist practitioners such as rheumatologists and endocrinologists who encounter it as a secondary manifestation of a primary systemic disorder. From a review of the literature we highlight the presentation of trigger finger, describe the processes involved in developing the condition, and rationalise the treatment options available. We have suggested guidelines and key points of note to aid practitioners in the management and referral of trigger finger and thumb in adults.
Sources and search criteria
We searched Medline and PubMed for relevant English language literature. We used the search terms "trigger finger" and "stenosing tenosynovitis." We identified additional literature from the references of these papers.
Presentation and progression
Trigger finger presents with discomfort in the palm during movement of the involved digits. Gradually, or in some cases acutely, the flexor tendon causes a painful click as the patient flexes and extends the digit. The patient may present with a digit locked in a particular position, usually in flexion, which may need gentle passive manipulation into full extension. Spontaneous resolution of symptoms can occur in patients with trigger thumb. 
Epidemiology
The condition has a reported incidence of 28 cases per 100 000 population per year, or a lifetime risk of 2.6% in the general population.
1 This rises to 10% in patients with diabetes. Two peaks in incidence occur-the first under the age of eight and the second (more common) in the fifth and sixth decades of life. This bimodal distribution represents two different clinical groups, not only for age but also in incidence, sex distribution, digit affected, treatment, and outcome (table).
Pathophysiology
Trigger finger arises through a discrepancy in the diameter of the flexor tendon and its sheath at the level of the metacarpal head. High pressures occur at the proximal edge of the A1 pulley on maximal flexion and during tight grip. Pressure is more evenly distributed in the remainder of the pulley system. In some patients this seems to have an adverse effect, causing changes in the macroscopic appearance of the A1 pulley with hypertrophy and fibrocartilaginous metaplasia at the tendon-pulley interface ( fig 1 and  fig 2) . 2 The thickening of the sheath, along with some localised tendon thickening, can result in a narrowed tunnel for tendon excursion and ultimately lead to a block to movement; the flexors are usually powerful enough to overcome this obstruction, whereas the weaker extensors are less able to counteract the block, resulting in the finger being locked in flexion. The A1 pulley is the site of disease in nearly all cases, owing to the high local forces and a steep pressure gradient; it is also the site of maximal tendon excursion. Alternative sites of tendon triggering have been described, including the A2 and A3 pulleys and the palmar aponeurosis.
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Summary points
Children can present with trigger finger/thumb, but it is less common than in adults; presentation is usually a fixed flexion deformity of the thumb In patients with diabetes, trigger finger is more common and less likely to respond to treatment than in patients without diabetes 
Causes
Various causes of trigger finger have been proposed, including repetitive finger movements or compressive forces at the A1 pulley and repetitive local trauma. [3] [4] [5] In such circumstances, occupation could be a major predisposing factor. However the available literature only partially supports that view. Bonnici and Spencer reported that 14/36 of their patients had occupations involving repetitive movement, 3 and Fahey and Bollinger observed that trigger finger was often seen in workers doing unaccustomed tasks in the workplace. 6 However, neither Anderson and Kaye nor Trazies et al found a correlation between the incidence of trigger finger and the workplace. 
Associated conditions
Incidence of trigger finger is increased in patients with diabetes. [9] [10] [11] In type 1 diabetes this correlation relates to duration of diabetes and not to diabetic control. 10 The prevalence is similar for type 1 and type 2 diabetes. 12 Patients with type 1 diabetes are more likely to have multiple digit involvement. 11 Patients with diabetes, especially type 1, are more difficult to treat and more likely to need surgery and protracted periods of physiotherapy than people without diabetes. 11 13 Patients with other common medical conditions such as hypothyroidism, 11 14 rheumatoid arthritis, 9 w5 gout, or renal failure, or rarer conditions such as amyloidosis, w6 are at higher risk of developing a trigger finger. Trigger finger also commonly coexists with local disorders such as carpal tunnel syndrome, de Quervain's tenovaginitis, and Dupuytren's contracture. 11 12 14 No association with pregnancy has been reported. 
Anatomy
The flexor sheath is a membranous structure, which surrounds the flexor tendons from the metacarpal neck to the volar plate of the distal interphalangeal joint and is attached longitudinally to the underlying bony structures. The sheath is thick over the bones (the annular pulley portion of the system) and thin in areas overlying the joints (cruciform pulley portion) to permit digital flexion. In maximal digital flexion, the edges of the annular pulleys approximate and in parts telescope while the cruciform pulleys concertina.
The A1 pulley marks the proximal border of the flexor sheath, and its surface markings can be identified from cadaver studies. If the distance between the proximal digital crease and the corresponding finger proximal interphalangeal joint crease is X cm, measuring X cm proximally from the proximal digital crease identifies the surface markings of the proximal border of the A1 pulley. The length of the A1 pulley has been found to be 1.17 cm ± 0.02 cm for the adult index, middle, and ring fingers and 0.98 cm ± 0.02 cm for the little finger (fig 3) . 15 The longitudinal axis of the neurovascular bundles follows the line of the digit in the ring finger and middle finger; however, the neurovascular bundles of the index and little fingers lie in a more diagonal axis, as they are situated beyond the medial and lateral edges of the distal end of the carpal tunnel. Consequently, the neurovascular bundles for these digits may cross over the A1 pulley (fig 4) . A practitioner must be alert to this if invasive interventions are being considered, as the radial digital nerve to the index finger and the ulnar digital nerve to the little finger will be particularly close to the pulley, putting them at risk of inadvertent damage.
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Treatment
Various methods have been used to treat trigger finger. We have reviewed the literature to obtain the evidence 5) .
Non-steroidal anti-inflammatory drugs
No evidence exists in the literature to suggest that nonsteroidal anti-inflammatory drugs alone have any benefit other than temporary relief of pain in the palm.
Splintage
The aim of splintage is to reduce or remove tendon excursion through the A1 pulley for a long enough time to allow the synovitis around the pulley to resolve. Rodgers et al found that treating manual workers, who used repetitive hand movements, with splintage of the distal interphalangeal joint for six weeks resulted in resolution of symptoms in 53% of patients. 17 Patel et al successfully treated 70% of digits by means of splintage of the metacarpophalangeal joint but were successful in treating only 50% of thumbs in this way. 18 In both studies, those patients with more severe disease and longer duration of symptoms were less likely to benefit from splintage.
Steroid injection
The injection of steroid into the flexor sheath was advocated as a method of treatment in 1950. Success rates between 38% and 93% have been reported. 7 9 14 Higher success rates are seen when injecting the thumb and in patients in whom a well defined nodule was palpable or whose symptoms had been present for less than six months. In patients in whom treatment fails or who have a recurrence of symptoms, a second steroid injection offers approximately half the efficacy of the first injection. 9 14 w8 No studies have shown that the steroid must be placed within the sheath to be effective; on the contrary, Taras et al showed that steroid injected into the subcutaneous tissue around the A1 pulley gave better clinical outcomes than that injected into the sheath alone.
w9 Injecting into the flexor sheath can prove difficult, as shown by Kamhin et al, who injected trigger fingers with dye and then went on to do an open A1 pulley release. They noted that only half of the injected fingers had dye within the sheath and that failure to introduce dye into the flexor sheath was higher in those patients with a longer duration of symptoms. 19 Complications include dermal or subcutaneous atrophy, skin hypopigmentation, infection, and in one rare case tendon rupture.
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Percutaneous trigger finger release Lorthioir first described percutaneous trigger finger release in 1958, and authors have since described its successful use in the outpatient department. 20 The technique involves placing the extended hand palm up with the metacarpophalangeal joints in a hyperextended position. The extended position facilitates access and ensures that the A2 pulley is held out to length and a maximal distance from the A1 pulley. The A1 pulley is stretched out and held stable in extension. The position also presents the pulley in a more superficial position, with the neurovascular bundles drawn medially and laterally away from the sheath. The tip of a 16/18 gauge needle is introduced through the skin on to the surface of the A1 pulley; the sharp tip of the needle is then used to incise the A1 pulley. Pope and Wolfe do not advise this method for release of a trigger index finger owing to proximity of the radial neurovascular bundle, 21 and Bain et al apply the same rationale (proximity of the ulnar digital nerve) for not using this technique for the little finger. 22 Cadaver studies, however, show that safe landmarks are available for percutaneous release for both little finger and index finger. 15 16 Success rates are over 90%. 23 w11 w12 Complications are rare but include digital nerve injury, bowstringing (if release extends into the A2 pulley), infection, haematoma, and persistent pain. 
Surgery
Surgery is done under local anaesthetic in the operating theatre. The A1 pulley is exposed through a palmar skin incision, and the pulley is divided under direct vision. Success rates vary from 60% to 97%. Complication rates can be high; complications include long term scar tenderness, inadequate release, nerve damage, and flexor sheath infection. 24 25 Treatment in children Children represent a distinct group of patients not only epidemiologically but also for treatment. The thumb is involved in 90% of cases. Treatment has traditionally entailed surgical release, but this has become increasingly controversial as authors have presented good results with non-operative methods of treatment.
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Non-operative methods of treatment include physiotherapy administered by the parents with or without splintage. With physiotherapy alone, success rates of between 52% and 80% cure have been reported in patients whose thumb is not fixed in flexion or extension.
w13 w14 With splintage, reports give success rates of 77-89%. In both groups, success rates seem to be higher in younger children and decrease with age. Contributors: FDB and DNQ provided the initial idea and goals to be achieved by the paper, MJB and SA reviewed the literature, and SA was responsible for collecting data and drafting the manuscript. All authors contributed to interpreting and revising the data. 
People who influenced my practice
Many doctors influence what we do by what they teach us. A few have disproportionate effects because they do not necessarily intend at that moment to instruct. This has happened to me on more than one occasion, and at least one affected my lifetime practice.
In the days when rigid bronchoscopy was current (the marvels of the flexible instrument had yet to be developed) the late Dr R Machray taught a method, ghastly to contemplate now, of local anaesthesia. He had just supervised my administration of cocaine to a conscious patient. The bronchoscopist, with whom he worked regularly, was Sir Clement Price Thomas, a doyen of both thoracic surgery and of bronchoscopy, who was, I thought, unlikely to need support from a tyro anaesthetist.
I therefore left the operating room, but Dr Machray hustled me back with his never to be forgotten words, "Make encouraging noises, my boy, make encouraging noises." From this I learnt that, to be successful with regional anaesthesia in a conscious patient, it is important to maintain contact with the patient, and thus sustain their confidence.
That lesson is simple and widely practised today. But it was his phraseology that struck me and has never left me since. 
John Lunn retired academic anaesthetist, Chepstow
